The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 29.3
Age-Adjusted SEER Cancer Incidence Trends, 1975-2016a
By International Classification of Childhood Cancer(ICCC)b Selected Group and Subgroupc
Excluding benign brain and myelodysplastic syndromes
All Races, Males and Females
| ICCC Group and Subgroup | Ages 0-14 | Ages 0-19 | ||||||
|---|---|---|---|---|---|---|---|---|
| % Change | APC | % Change | APC | |||||
| 1975-2016 | 1975-2016 | 1975-1995 | 1996-2016 | 1975-2016 | 1975-2016 | 1975-1995 | 1996-2016 | |
| All ICCC Groups Combined | 44.2 | 0.6* | 0.8* | 0.6* | 42.8 | 0.7* | 0.8* | 0.8* |
| I Leukemia | 62.0 | 0.7* | 0.7* | 0.6* | 63.1 | 0.7* | 0.7* | 0.7* |
| I(a) Lymphoid leukemia | 79.9 | 0.7* | 0.9* | 0.4 | 86.7 | 0.8* | 0.9* | 0.6* |
| I(b) Acute myeloid leukemia | 44.1 | 1.0* | 1.2 | 0.2 | 31.3 | 0.9* | 1.1 | 0.1 |
| II Lymphomas and reticuloendothelial neo. | -2.4 | 0.3* | -0.8* | 1.2*# | -0.9 | 0.2* | -0.1 | 0.9*# |
| II(a) Hodgkin lymphoma | -36.0 | -0.6* | -1.7* | 0.1# | -30.0 | -0.5* | -0.8 | 0.1 |
| II(b,c,e) Non-Hodgkin lymphoma | 23.5 | 1.0* | 0.0 | 2.2*# | 46.6 | 1.2* | 0.9* | 1.9*@ |
| III CNS & misc intracranial & intraspinal neo. | 35.5 | 0.8* | 2.1* | 0.3# | 22.8 | 0.7* | 1.8* | 0.4# |
| III(a) Ependymomas and choroid plexus tumors | - | - | - | 1.3* | - | - | - | 1.3* |
| III(b) Astrocytoma | 48.7 | 0.9* | 2.8* | 0.5# | 32.4 | 0.7* | 2.2* | 0.8# |
| III(c) Intracranial and intraspinal embryonal tum. | 139.3 | 0.7* | 1.8* | -0.6# | 137.3 | 0.8* | 2.0* | -0.7# |
| III(d) Other gliomas | -35.0 | 0.5 | 0.3 | 0.2 | -42.6 | 0.6* | 0.7 | 0.0 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 16.2 | 0.3 | 0.5 | 0.3 | 15.9 | 0.3 | 0.4 | 0.3 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 12.8 | 0.4 | 0.4 | 0.3 | 12.7 | 0.3 | 0.3 | 0.3 |
| V Retinoblastoma | 20.4 | 0.2 | 1.3 | -0.2@ | 20.4 | 0.2 | 1.4 | -0.2@ |
| VI Renal tumors | 51.3 | 0.0 | 0.6 | 0.0 | 50.1 | 0.1 | 0.7 | 0.1 |
| VI(a) Nephroblastoma and other nonepithelial renal tumors | 49.1 | 0.0 | 0.4 | -0.1 | 49.1 | 0.0 | 0.5 | -0.1 |
| VII Hepatic tumors | - | - | - | - | - | - | - | - |
| VII(a) Hepatoblastoma | - | - | - | - | - | - | - | - |
| VIII Malignant bone tumors | 84.4 | 0.4 | 0.9 | 1.3* | 37.3 | 0.3 | 1.0* | 0.7 |
| VIII(a) Osteosarcoma | - | - | - | 1.4 | 83.9 | 0.6* | 1.7* | 0.8 |
| VIII(c) Ewing tum. and related sarcomas of bone | 36.2 | - | - | - | 5.6 | -0.1 | 0.3 | 0.6 |
| IX Soft tissue and other extraosseous sarcomas | 41.5 | 0.6* | 0.7 | 0.6 | 68.7 | 0.6* | 0.5 | 0.2 |
| IX(a) Rhabdomyosarcoma | 54.1 | 0.3 | 1.2 | 0.3 | 55.9 | 0.2 | 1.2 | 0.0 |
| X Germ cell & trophoblastic tum. & neo. of gonads | 46.3 | 0.9* | 1.4 | 0.2 | 12.4 | 0.7* | 1.5* | 0.5@ |
| X(a) Intracranial and intraspinal germ-cell tum. | - | - | - | - | - | - | - | - |
| X(c) Malignant gonadal germ cell tumors | 11.4 | - | - | - | 15.7 | 0.7* | 1.3* | 0.3 |
| XI Other malignant epithelial neo. and melanomasd | 85.4 | 1.7* | 0.4 | 3.0*# | 121.7 | 1.6* | 0.9* | 2.8*# |
| XI(b) Thyroid carcinoma | 60.8 | - | - | - | 193.6 | 2.4* | 0.8 | 4.6*# |
| XI(d) Malignant melanoma | - | - | - | - | 50.8 | 0.7* | 1.5 | -1.0# |
Footnotes:
The APC is the Annual Percent Change over the time interval.
a SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta).
b International Classification of Childhood Cancer is based on ICD-O-3. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer. April 1, 2005: Vol 103, No. 7 , pg 1457-1467.
c Classifications are shown for invasive cases only except as noted. For ICCC groups and subgroups that include in situ behavior, only invasive cases are shown except as noted.
d Includes in situ urinary bladder tumors.
* The APC is significantly different from zero (p<.05)
# The APC for 1996-2016 is significantly different from the APC for 1975-1995 (p<.05).
@ The APC for 1996-2016 is significantly different from the APC for 1975-1995 (p<.10).
- Statistic could not be calculated. Trend based on less than 10 cases for at least one year within the time interval.
Neoplasms are abbreviated as neo. Tumors are abbreviated as tum.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.